PYC Therapeutics eyes key RNA therapy clinical milestones by 2028
PYC Therapeutics is advancing RNA therapies for rare diseases, progressing multiple clinical programs. Efficacy data is expected in the next 18 months, with registrational studies targeted for 2028.
Focused on advancing RNA therapies for rare diseases, the company is expanding its leadership and progressing multiple clinical programs, with key efficacy data expected in the next 18 months and registrational studies targeted for 2028.Original document: PYC Therapeutics Limited [PYC] Slides Relea…